Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
03/2014
03/27/2014US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
03/26/2014EP2709986A1 Deuterated derivatives of ivacaftor
03/26/2014CN103687591A Capsule formulation comprising montelukast and levocetirizine
03/26/2014CN103664879A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664876A Quinoline derivative and usage thereof
03/26/2014CN103664779A Preparation method of pefloxacin mesylate
03/26/2014CN103664778A Synthesis method of antineoplastic drug cabozant inib
03/26/2014CN103664777A 2-undecyl-3-methyl-hydroxyl-quinoline compound as well as preparation method, pharmaceutical composition and use thereof
03/26/2014CN103664776A Preparation method for tyrosine kinase inhibitor and midbody thereof
03/26/2014CN103664775A Aripiprazole intermediate synthesis method
03/26/2014CN103664774A Preparation method for pitavastatin calcium intermediate
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103664748A Pyrene compound and organic light emitting diode device including the same
03/26/2014CN103664747A Preparation method for heterocyclic biphenyl compound
03/26/2014CN103664746A Anthracene compound and organic light emitting diode including the same
03/26/2014CN103664646A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/26/2014CN103664433A Preparation method for aromatic nitrile compound
03/26/2014CN102816116B Synthetic method of 6-hydroxyl-2(1H)-quinolinone compound
03/26/2014CN102816115B Synthetic method of hydroxy-substituted-3,4-dihydro-2(1H)-quinolinone compound
03/26/2014CN102625797B Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
03/26/2014CN101747888B Red phoshorescent compound and organic electroluminescent device using the same
03/25/2014US8680279 Compounds for the treatment of neurological disorders
03/25/2014US8680278 Enantioselective process for preparing a substituted alkanoic acid
03/25/2014US8680116 Quinolinone PDE2 inhibitors
03/25/2014US8680114 AKT protein kinase inhibitors
03/25/2014CA2621988C Quinoline derivatives and use as antitumor agents
03/25/2014CA2585983C Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
03/20/2014WO2014043437A1 Amino-quinolines as kinase inhibitors
03/20/2014US20140080867 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
03/20/2014US20140080866 Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
03/20/2014US20140080831 Compounds useful for treating cancer
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/19/2014CN103649053A Aminomethyl quinolone compounds
03/19/2014CN103642489A Quinaldine derivative a fluorescent reagent as well as preparation method and application thereof
03/19/2014CN103641779A Quinaldine derivative b fluorescent and colorimetric reagent as well as preparation method and application thereof
03/19/2014CN103641778A Method for extracting quinoline and isoquinoline from coal tar wash oil
03/19/2014CN103641765A Modulators of ATP-binding cassette transporters
03/18/2014US8674108 Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
03/18/2014US8674107 Crystal of anti-bacterial compound
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8673322 Crystals of laquinimod sodium, and process for the manufacture thereof
03/13/2014WO2014036595A1 Compounds and methods for treating diseases or conditions associated with the central nervous system and/or neurite outgrowth
03/13/2014US20140073668 N-quinolin-benzensulfonamides and related compounds for the treatment of cancer, autoimmune disorders and inflammation
03/13/2014US20140073667 Deuterated cftr potentiators
03/13/2014US20140073631 Antiviral and antimicrobial compounds
03/13/2014US20140073500 Class of organic compounds containing heteroatom and its applications in preparing single-site ziegler-natta catalyst
03/13/2014US20140072555 Inhibitor Compounds and Cancer Treatment Methods
03/12/2014EP2705011A1 Novel precursors of glutamate derivatives
03/12/2014CN103626702A Preparation method for quinolinone derivatives
03/12/2014CN103626701A Quinoline derivative preparation method
03/12/2014CN103626700A Salt of cyclopropane dicarboxamide derivative
03/12/2014CN103626699A Industrial preparation method of 4,7-dichloroquinoline
03/12/2014CN103626698A Method for purifying 2-methylquinoline
03/12/2014CN103626690A Method for directly synthesizing nitrogenous heterocyclic aromatic hydrocarbon compound with aromatic hydrocarbon compound
03/12/2014CN102186824B Fused-ring derivative and medical application of same
03/12/2014CN101679191B Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/12/2014CN101641332B Derivatives of aminated hydroxyquinoline class for treating cancers
03/11/2014CA2608493C Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
03/06/2014WO2014034719A1 Quinoline derivative having tlr inhibitory activity
03/06/2014WO2014034203A1 Method for producing high-purity montelukast
03/06/2014US20140066478 Beta2-Adrenoreceptor Agonists
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/05/2014EP2703385A1 Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material
03/05/2014EP2702042A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/05/2014CN103619820A Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/05/2014CN103619819A Method for producing fine particles of aripiprazole anhydride crystals B
03/05/2014CN103619818A Heterocyclic compounds for treating helminth infections
03/05/2014CN103619817A Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
03/05/2014CN103614135A Two-photon fluorescent probe as well as preparation method and application thereof
03/05/2014CN103613785A Preparation method of antioxidant 224 by employing solid sulfuric acid as catalyst
03/05/2014CN103613539A Preparation method of hydroquinoline
03/05/2014CN103613538A Catalytic synthesis process of rubber antioxidant 224
03/05/2014CN103613537A Clean high-efficiency synthetic method of high-content anti-aging agent RD
03/04/2014US8664399 Substituted heterocyclic compounds as ion channel modulators
03/04/2014US8664398 Moxifloxacin hydrochloride compounds and intermediates and methods for making same
03/04/2014US8664379 Fused heterocyclic compounds as ion channel modulators
03/04/2014US8664264 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/04/2014US8664244 Compounds as c-Met kinase inhibitors
02/2014
02/27/2014WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections
02/27/2014WO2014031584A1 Haptens of aripiprazole and their use in immunoassays
02/27/2014WO2014029723A1 New bicyclicpyridine derivatives
02/27/2014WO2014029713A1 Method for producing linear and/or cyclic carbonate esters
02/27/2014WO2014029007A1 Protein kinase inhibitors
02/27/2014WO2014001215A3 3-o-heteroaryl-ingenol
02/27/2014US20140058109 Crystal form of quinoline compound and process for its production
02/27/2014US20140057943 Method of Treating Cancer
02/27/2014US20140057908 Method of Treating Cancer
02/26/2014EP2700633A1 Method for producing linear and/or cyclic carbonate esters
02/26/2014EP2700403A1 Therapeutic agent for tumor
02/26/2014EP2699560A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
02/26/2014EP2699551A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
02/26/2014EP2699550A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
02/26/2014EP2699549A1 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
02/26/2014CN103601677A Preparation method of 2-alkylsulfenylquinoline derivative
02/26/2014CN103601676A Synthetic method for high-enantioselectivity N-acetyl-2-substitued-2, 3-dihydro-4-quinolinone compounds
02/26/2014CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof
02/26/2014CN102731392B Platinum characteristic complexing agent, preparation method and application for extracting, and enriching and testing platinum
02/26/2014CN102417479B STAT3 small molecular selective inhibitor and preparation method and application thereof
02/26/2014CN101671301B Heterocyclic substituent acardite derivate and application thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 277